Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-21.26	98.64	125.27
Graham Fair Price	-9.75	96.54	106.97
PEG	60.37	-2.41	-6.08
Price/Book	10.95	4.88	4.40
Price/Cash Flow	296.71	245.60	61.91
Prices/Earnings	32.66	41.80	31.51
Price/Sales	13.74	21.46	18.87
Price/FCF	296.71	245.60	61.91
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1.30	0.41	0.41
Operating Margin	-2.38	0.17	0.17
ROA	-17.16	0.01	0.02
ROE	0.03	0.03	-16.37
ROIC	0.02	0.02	-28.60
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	-0.01	90.26
Dividends QOQ	< 0.005	< 0.005	17.39
EBIT QOQ	< 0.005	-0.07	-1247.23
EPS QOQ	-0.05	-0.17	-234.73
FCF QOQ	0.59	-0.73	22.55
Revenue QOQ	0.03	-0.05	68.43
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	71.66	75.39	5.20
Days Sales Outstanding (DSO)	67.97	81.37	19.72
Inventory Turnover	1.26	1.19	-4.94
Debt/Capitalization	0.43	0.44	2.63
Quick Ratio	1.16	1.19	2.46
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	120.73	119.15	-1.31
Cash	20.87	19.00	-8.98
Capex	-1.05	-0.91	13.20
Free Cash Flow	8.57	2.37	-72.40
Revenue	28.13	27.08	-3.73
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.75	1.70	-3.34
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	14.48	11.78	-18.65
Naive Interpretation	Member

06 - Financial Health · Weak

Rating